jRCT1031220613
Untitled Trial
Biomarker study of FTD/TPI and Bevacizumab as Salvage line chemotherapy for colorectal cancer. (TAS CC5 Study)
Takeshi Yamada·Japan Registry Clinical TrialRecruiting
Study focus
- Disease/Condition
- colorectal cancer
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Takeshi Yamada
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Descending colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT1031220613
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT1031220613 through Pure Global AI's free database. This phase not specified trial is sponsored by Takeshi Yamada and is currently Recruiting. The study focuses on colorectal cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.